- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1307
Companies which are more than 50% undervalued based on analyst price target.
1,307 companies
Marvell Technology
Market Cap: US$51.7b
Provides data infrastructure semiconductor solutions, spanning the data center core to network edge.
MRVL
US$64.50
7D
4.1%
1Y
-6.5%
JD.com
Market Cap: US$48.8b
Operates as a supply chain-based technology and service provider in the People’s Republic of China.
JD
US$36.05
7D
5.8%
1Y
6.7%
BioMarin Pharmaceutical
Market Cap: US$11.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$61.37
7D
-1.1%
1Y
-23.8%
Moderna
Market Cap: US$9.4b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$25.70
7D
-7.7%
1Y
-79.5%
VinFast Auto
Market Cap: US$8.7b
Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.
VFS
US$3.75
7D
7.4%
1Y
-17.8%
AST SpaceMobile
Market Cap: US$8.4b
Designs and develops the constellation of BlueBird satellites in the United States.
ASTS
US$27.16
7D
9.7%
1Y
1,112.5%
Roivant Sciences
Market Cap: US$7.6b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.
ROIV
US$10.99
7D
-5.0%
1Y
-1.7%
Revolution Medicines
Market Cap: US$7.5b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$41.88
7D
5.2%
1Y
12.7%
Corcept Therapeutics
Market Cap: US$7.4b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$72.13
7D
-2.4%
1Y
162.0%
EchoStar
Market Cap: US$7.0b
Provides networking technologies and services in the United States and internationally.
SATS
US$20.18
7D
-15.5%
1Y
27.2%
UWM Holdings
Market Cap: US$6.8b
Engages in the origination, sale, and servicing residential mortgage lending in the United States.
UWMC
US$4.25
7D
-10.9%
1Y
-38.8%
BridgeBio Pharma
Market Cap: US$6.5b
A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
BBIO
US$35.68
7D
-6.6%
1Y
25.2%
Jazz Pharmaceuticals
Market Cap: US$6.0b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$103.58
7D
-12.4%
1Y
-8.5%
Legend Biotech
Market Cap: US$5.8b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$32.38
7D
-3.1%
1Y
-24.6%
Lantheus Holdings
Market Cap: US$5.7b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$79.52
7D
-26.4%
1Y
2.1%
Axsome Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$110.16
7D
-5.4%
1Y
45.6%
Ionis Pharmaceuticals
Market Cap: US$5.1b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$33.53
7D
-0.3%
1Y
-13.6%
Nuvalent
Market Cap: US$5.0b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$73.63
7D
-2.4%
1Y
11.4%
ChampionX
Market Cap: US$4.8b
Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.
CHX
US$26.06
7D
6.2%
1Y
-24.3%
Icahn Enterprises
Market Cap: US$4.6b
Through its subsidiaries engages in the investment, energy, automotive, food packaging, real estate, home fashion and pharma in the United States and internationally.
IEP
US$9.17
7D
3.5%
1Y
-50.1%
BGC Group
Market Cap: US$4.5b
Operates as a financial brokerage and technology company in the United States, Europe, the Middle East, Africa, and the Asia Pacific.
BGC
US$9.29
7D
-1.3%
1Y
7.8%
Onto Innovation
Market Cap: US$4.3b
Engages in the design, development, manufacture, and support of process control tools that performs optical metrology and inspection worldwide.
ONTO
US$93.49
7D
-24.8%
1Y
-57.8%
Vaxcyte
Market Cap: US$4.1b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$31.59
7D
8.0%
1Y
-53.1%
Copa Holdings
Market Cap: US$4.1b
Through its subsidiaries, provides airline passenger and cargo transport services.
CPA
US$99.13
7D
4.6%
1Y
-6.5%
Telephone and Data Systems
Market Cap: US$4.0b
A telecommunications company, provides communications services to consumer, business, and government in the United States.
TDS
US$33.75
7D
6.3%
1Y
60.9%
Oklo
Market Cap: US$3.9b
Develops advanced fission power plants to provide clean, reliable, and affordable energy at scale to the customers in the United States.
OKLO
US$28.85
7D
13.3%
1Y
195.3%
Krystal Biotech
Market Cap: US$3.8b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$139.43
7D
-14.1%
1Y
-9.9%
Cytokinetics
Market Cap: US$3.8b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$32.13
7D
-12.4%
1Y
-44.5%
Sarepta Therapeutics
Market Cap: US$3.6b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
SRPT
US$36.37
7D
-22.2%
1Y
-72.6%
Core Natural Resources
Market Cap: US$3.5b
Produces, sells, and exports metallurgical and thermal coals in the United States and internationally.
CNR
US$68.41
7D
-7.8%
1Y
-21.4%
GEO Group
Market Cap: US$3.5b
Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.
GEO
US$26.16
7D
-16.6%
1Y
100.0%
Abercrombie & Fitch
Market Cap: US$3.5b
Through its subsidiaries, operates as an omnichannel retailer in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
ANF
US$78.17
7D
12.6%
1Y
-41.0%
Avidity Biosciences
Market Cap: US$3.4b
A biopharmaceutical company, engages in the delivery of RNA therapeutics.
RNA
US$29.33
7D
-9.1%
1Y
12.7%
Weatherford International
Market Cap: US$3.3b
An energy services company, provides equipment and services for the drilling, evaluation, completion, production, and intervention of oil, geothermal, and natural gas wells worldwide.
WFRD
US$48.88
7D
12.3%
1Y
-60.2%
Ultragenyx Pharmaceutical
Market Cap: US$3.3b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE
US$36.09
7D
-7.2%
1Y
-11.9%
Liberty Global
Market Cap: US$3.2b
Provides broadband internet, video, fixed-line telephony, and mobile communications services to residential and business customers.
LBTY.A
US$9.23
7D
-3.8%
1Y
-45.0%